Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0305340 INHIBITORS OF BRUTON'S TYROSINE KINASE
This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein, which inhibit Btk. The compounds...
2018/0305339 Heteroarylcarboxamide Derivatives as Plasma Kallikrein Inhibitors
Disclosed are heteroarylcarboxamides of formula (I), ##STR00001## and pharmaceutically acceptable salts thereof, wherein A, T, R.sup.1, R.sup.2 and R.sup.3 are...
2018/0305338 HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
The present invention relates to compounds of general formula I, wherein D.sup.1 to D.sup.3, A, R.sup.1, R.sup.2, Y and n are defined as in claim 1, which have...
2018/0305337 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. An organic ...
2018/0305335 2-HALO-5-ALKYNYL-PYRIDYL NICOTINIC LIGANDS
Disclosed are heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. The compounds are useful for treating a mammal suffering from any...
2018/0305334 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES
Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases,...
2018/0305333 SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR...
Solid forms comprising 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the solid forms, methods of making the...
2018/0305332 Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their Use
In its many embodiments, the present invention provides certain substituted bispiperidinyl compounds of the Formula (I): and pharmaceutically acceptable salts...
2018/0305331 PYRIDONE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS
Disclosed in the present application is a compound of formula (I) as defined herein as well as a pharmaceutical composition comprising said compound. Further...
2018/0305330 MATERIALS AND METHOD FOR INHIBITING REPLICATION PROTEIN A AND USES THEREOF
Targeting uncontrolled cell proliferation and resistance to DNA damaging chemotherapeutics with at least one reagent has significant potential in cancer...
2018/0305329 XANTHINE COMPOUND AND USE THEREOF
A fluorescent probe for measurement of CYP3A activity, having an excellent CYP molecular species selectivity and detection sensitivity represented is...
2018/0305328 Novel compounds for treating mitochondrial disease
The invention relates to novel compounds that are useful for modulating cellular ROS. The compounds are amide-derivatives of ...
2018/0305327 SUBSTITUTED DIHYDROBENZOFURAN COMPOUNDS AND THEIR USE AS SYNERGISTS
The invention relates to a substituted dihydrobenzofuran compound of Formula (I), wherein R.sub.1 is a linear (C.sub.3-C.sub.6)alkyl and an insecticide...
2018/0305326 NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND
This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase...
2018/0305325 METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS (2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)- 1,3,5- TRIAZINE COMPOUND...
The present invention provides methods respectively for producing a 2,4,6-tris(2-hydroxy-3-methyl-4-alkoxyphenyl)-1,3,5-triazine compound and ...
2018/0305324 BIS(AMINOPHENYLPHENOL) LIGANDS AND TRANSITION METAL COMPOUNDS PREPARED THEREFROM
Disclosed are novel bis(aminophenylphenol) ligands and transition metal compounds derived therefrom. Also disclosed are methods of making the ligands and...
2018/0305323 Prolyl Hydroxylase Inhibitors
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I) ##STR00001## which are antagonists of HIF...
2018/0305322 SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF...
Provided herein are Diaminopyrimidine Compounds having the following structures: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are as ...
2018/0305321 COMPOUNDS, COMPOSITIONS, AND METHODS FOR CONTROLLING BIOFILMS
The present invention relates to substituted 5-aryl-2-aminoimidiazole compounds being active against microbial biofilm formation. The invention also relates to...
2018/0305320 SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
The present invention relates to compounds according to Formula I: and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment...
2018/0305319 Process for the Preparation of Carbamoylamino Pyrazole Derivatives
The present invention relates to a process for the preparation of carbamoylamino pyrazole derivatives using diacetoxyiodobenzene (PhI(OAc).sub.2) in...
2018/0305318 INHIBITORS OF OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR 1 AND METHODS OF USE THEREOF
Inhibitors of oxidized low-density lipoprotein receptor 1 (LOX-1), compositions comprising inhibitors of LOX-1, and methods of using thereof are described.
2018/0305317 ALKYNYL PYRIDINE PROLYL HYDROXYLASE INHIBITOR, AND PREPARATION METHOD AND MEDICAL USE THEREOF
The present invention relates to the field of pharmaceutical chemistry. In particular, the present invention relates to a class of alkynyl pyridine prolyl...
2018/0305316 COMPOUNDS, COMPOSITIONS AND METHODS
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of...
2018/0305315 PD-1/PD-L1 INHIBITORS
Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the...
2018/0305314 POTENT NON-UREA INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase...
2018/0305313 COLORED PHOTOSENSITIVE RESIN COMPOSITION AND LIGHT SHIELDING SPACER PREPARED THEREFROM
Disclosed herein is a colored photosensitive resin composition including a copolymer, an epoxy resin compound or a compound derived therefrom, a polymerizable...
2018/0305312 EBNA1 INHIBITORS AND METHODS USING SAME
The present invention provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused...
2018/0305311 SYNERGISTIC COMPOSITIONS
The present invention describes a synergistic composition comprising of one or more statins, or one or more dipeptidyl peptidase IV (DPP IV) inhibitor or one...
2018/0305310 Augmenting Moieties for Anti-Inflammatory Compounds
Augmented or synergized anti-inflammatory constructs are disclosed including anti-inflammatory amino acids covalently conjugated with other anti-inflammatory...
2018/0305309 Synthesis of Succinimides and Quaternary Ammonium Ions for Use in Making Molecular Sieves
The present invention relates to the synthesis of succinimides, in particular to a method for the synthesis of a succinimide compound, comprising the step of...
2018/0305308 INDUSTRIAL PROCESS FOR THE PREPARATION OF (5S, 10S)-10-BENZYL-16-METHYL-11, 14, 18-TRIOXO-15, 17, ...
The present invention relates to an industrial process for the preparation of (5S,10S)-10-benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trithi- ...
2018/0305307 COMPOUNDS AS L-CYSTINE CRYSTALLIZATION INHIBITORS AND USES THEREOF
A method of preventing or inhibiting L-cystine crystallization is disclosed, using the compounds of formula I: ...
2018/0305306 Mixed Branched Eicosyl Polysulfide Compositions and Methods of Making Same
A composition comprising polysulfides, wherein at least about 50 wt. % of the polysulfides are branched C.sub.20 to C.sub.60 polysulfides represented by...
2018/0305305 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME
The invention includes 2-.beta.-naphthyl-acetic acid derivatives, which are selective AKR1C3 inhibitors. In certain embodiments, the compounds of the invention...
2018/0305304 N-HYDROXYLSULFONAMIDE DERIVATIVES AS NITROXYL DONORS
The disclosed subject matter provides N-hydroxylsulfonamide derivative compounds of formulae (I), (II) or (III) as drawn below, pharmaceutical compositions...
2018/0305303 Method for preparing acrolein cyanohydrins
The present invention relates to an improved method for preparing acrolein cyanohydrins from hydrocyanic acid and the corresponding acroleins. The method is...
2018/0305302 METHOD FOR SYNTHESIZING 2-ALKYL-4-TRIFLUOROMETHYL-3-ALKYLSULFONYLBENZOIC ACIDS
A process for preparing 2-alkyl-4-trifluoromethyl-3-alkylsulfonylbenzoic acids of the formula (I) is described. ##STR00001## Here, the substituents are radicals...
2018/0305301 METHOD FOR PREPARATION OF 5-ALKYLSALICYLALDOXIMES AND APPLICATION THEREOF
Method for preparation of 5-alkylsalicylaldoximes with formula 1, where R is a C6-C16 alkyl group, consisting in that into a water-alcohol solvent system,...
2018/0305300 NOVEL LIGNANAMIDES AND A METHOD OF TREATING NEURODEGENERATIVE DISEASES BY USING THE SAME
One example embodiment is a lignanamide that includes a benzo-angular triquinane skeleton. The lignanamide is represented by formula (I) and any derivative of...
2018/0305299 N-(2-FLUORO-2-PHENETHYL)CARBOXAMIDES AS NEMATICIDES AND ENDOPARASITICIDES
The present invention relates to N-(2-halogen-2-phenethyl)carboxamides, a process for producing such compounds, their use for the control of nematodes in...
2018/0305298 DEUTERATED CHLOROKYNURENINES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
Described are deuterated chlorokynurenines and compositions, and their application as pharmaceuticals for the treatment of disease. Methods of modulating...
2018/0305297 DTPA PRODRUGS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
The present invention relates to trisodium diethylenetriamine pentaacetic acid (DTPA) prodrugs, such as, for example, DTPA di-ethyl esters. The invention...
2018/0305296 ACETYLSALICYLIC ACID DERIVATIVE CRYSTAL, ITS PREPARATION METHOD AND USE
Disclosed are an acetylsalicylic acid derivative, i.e. a 2-(diethylamino)ethyl 2-acetoxy-benzoate hydrochloride crystal, and a preparation method and use...
2018/0305295 PROCESS FOR PREPARING Z-ENDOXIFEN OF HIGH PURITY
Disclosed is a process for preparing (Z)-endoxifen, comprising (i) recrystallizing an input crystalline solid comprising a mixture of (Z)-endoxifen (1) and...
2018/0305294 NANOCOMPOSITE HOLLOW SPHERE AS A PHOTOCATALYST AND METHODS THEREOF
A photocatalytic nanocomposite hollow sphere comprising a shell surrounding a hollow core, and the shell comprising zirconium dioxide, hydroxyapatite, and...
2018/0305293 TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any...
2018/0305292 DERIVATIVES OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
The present invention relates to novel compounds, e.g. for use as a medicament. In particular, the present invention relates to novel derivatives of certain...
2018/0305291 HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL...
A highly unsaturated fatty acid or a highly unsaturated fatty acid ethyl ester that has been produced using as a feedstock oil a fat or oil that contains...
2018/0305290 METHOD FOR CONTINUOUSLY PRODUCING KETOMALONIC ACID COMPOUND USING FLOW REACTOR
The purpose of the present invention is to provide a method for continuously producing a ketomalonic acid compound such as a ketomalonic acid diester or a...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.